Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Abstract:
      Aims. To compare a transdermal nicotine patch designed for 24-hour wear with one designed for 16-hour wear for relief of craving and withdrawal, particularly in the morning hours. Design. Smokers were randomly assigned to use one of two common patch regimens: NicoDerm/NiQuitin (24-hour wear, 21 mg nicotine) or Nicotrol/Nicorette (16-hour wear, 15 mg). In a double-dummy design, participants wore two patches during the day, one active, one placebo and one patch while sleeping. Setting. A smoking cessation research clinic. Participants. Two hundred and forty-four smokers who suffered morning cravings. Intervention. Two patch formulations approved and marketed for over-the-counter use in the US- NicoDerm CQ (labeled as 21 mg over 24 hours) and Nicotrol (labeled as 15 mg over 16 hours)-were each used according to its instructions. Smokers also received behavioral counseling. Measurements. For a week of baseline and 2 weeks after quitting, smokers used palm-top computers to assess craving and withdrawal symptoms several times each day. Findings. The 21 mg/24-hour patch yielded consistently better control of craving, not only during the morning hours, but throughout the day, and over the 2-week period of abstinence. Additionally, the 21 mg/24-hour patch yielded greater reductions in anxiety, irritability and restlessness. Smokers using the 21 mg/24-hour dosing regimen also experienced longer abstinence than those using the 15 mg/16-hour patch. Conclusions. These findings demonstrate that 24-hour dosing with a 21 mg patch affords superior relief of craving and withdrawal during the first 2 weeks of abstinence, when symptoms are at their peak, and when relapse is most likely. They confirm the importance of dosing parameters in nicotine replacement products. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Addiction is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
    • Author Affiliations:
      1University of Pittsburgh, invivoData, Inc. & Pinney Associates, Pittsburgh, PA, USA
      2invivoData, Inc.
      3University of Pittsburgh
    • Full Text Word Count:
      6296
    • ISSN:
      0965-2140
    • Accession Number:
      10.1046/j.1360-0443.2000.95811855.x
    • Accession Number:
      3476022
  • Citations
    • ABNT:
      SHIFFMAN, S. et al. Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving. Addiction, [s. l.], v. 95, n. 8, p. 1185–1195, 2000. DOI 10.1046/j.1360-0443.2000.95811855.x. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=a9h&AN=3476022. Acesso em: 27 set. 2020.
    • AMA:
      Shiffman S, Elash CA, Paton SM, Gwaltney CJ, Paty JA, Clark DB. Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving. Addiction. 2000;95(8):1185-1195. doi:10.1046/j.1360-0443.2000.95811855.x
    • APA:
      Shiffman, S., Elash, C. A., Paton, S. M., Gwaltney, C. J., Paty, J. A., & Clark, D. B. (2000). Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving. Addiction, 95(8), 1185–1195. https://doi.org/10.1046/j.1360-0443.2000.95811855.x
    • Chicago/Turabian: Author-Date:
      Shiffman, S., C. A. Elash, S. M. Paton, C. J. Gwaltney, J. A. Paty, and D. B. Clark. 2000. “Comparative Efficacy of 24-Hour and 16-Hour Transdermal Nicotine Patches for Relief of Morning Craving.” Addiction 95 (8): 1185–95. doi:10.1046/j.1360-0443.2000.95811855.x.
    • Harvard:
      Shiffman, S. et al. (2000) ‘Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving’, Addiction, 95(8), pp. 1185–1195. doi: 10.1046/j.1360-0443.2000.95811855.x.
    • Harvard: Australian:
      Shiffman, S, Elash, CA, Paton, SM, Gwaltney, CJ, Paty, JA & Clark, DB 2000, ‘Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving’, Addiction, vol. 95, no. 8, pp. 1185–1195, viewed 27 September 2020, .
    • MLA:
      Shiffman, S., et al. “Comparative Efficacy of 24-Hour and 16-Hour Transdermal Nicotine Patches for Relief of Morning Craving.” Addiction, vol. 95, no. 8, Aug. 2000, pp. 1185–1195. EBSCOhost, doi:10.1046/j.1360-0443.2000.95811855.x.
    • Chicago/Turabian: Humanities:
      Shiffman, S., C. A. Elash, S. M. Paton, C. J. Gwaltney, J. A. Paty, and D. B. Clark. “Comparative Efficacy of 24-Hour and 16-Hour Transdermal Nicotine Patches for Relief of Morning Craving.” Addiction 95, no. 8 (August 2000): 1185–95. doi:10.1046/j.1360-0443.2000.95811855.x.
    • Vancouver/ICMJE:
      Shiffman S, Elash CA, Paton SM, Gwaltney CJ, Paty JA, Clark DB. Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving. Addiction [Internet]. 2000 Aug [cited 2020 Sep 27];95(8):1185–95. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=a9h&AN=3476022